Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1143564

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1143564

U.S. Medical Marijuana Market Size By Application, Route of Administration, Distribution Channel, Industry Analysis Report, Zonal Outlook, Zone Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022-2030

PUBLISHED:
PAGES: 225 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The U.S. medical marijuana market size is poised to witness substantial growth over the forecast years 2022 to 2030. Increasing government efforts to legalize marijuana for medical purposes has helped authorize product consumption across more than two-thirds of U.S. States. Agencies like the U.S. Food and Drug Administration (FDA) have permitted medical marijuana-based treatment for two rare and severe forms of epilepsy, namely Lennox-Gastaut syndrome and Dravet syndrome.

Growing efforts to determine the efficacy of cannabis-infused medical supplements to aid cancer patients or individuals with other neurological conditions will positively affect the industry outlook. In April 2022, the U.S. House of Representatives passed a bipartisan marijuana research bill, allowing scientists access to marijuana at dispensaries of legal cannabis states. The Marijuana Opportunity Reinvestment & Expungement Act is expected to boost R&D, access, and further development of novel medical marijuana products.

The U.S. medical marijuana market is categorized into the application, route of administration, distribution channel, and region.

With respect to application, the industry is bifurcated into pain management, seizures, anorexia, muscle spasms, and nausea. The market share from the seizures segment exceeded USD 305 million in 2021.

Medical marijuana is widely used to treat seizures, which occur on uncontrolled electrical disturbances in the human brain. Epilepsy is one such seizure-inducing health condition that affects nearly 3.4 million people in the U.S. The rising prevalence of seizures in the U.S. will fuel demand for medical marijuana.

Based on the route of administration, the U.S. medical marijuana market is fragmented into oral, inhalation, and topical. Among these, the market share from the inhalation segment is projected to exhibit over 10% CAGR between 2022-2030. Administration of medical marijuana with the help of inhalers allows the drug to reach target organs and thus requires a lesser dosage. A medical marijuana inhaler delivers accurate quantities of THC and CBD to provide relief from discomfort, and tension.

In terms of distribution channel, the industry is classified into online, and dispensaries. Among these, the online segment accounted for over 39.9% share of the U.S. medical marijuana market in 2021. Rise in the number of online drug stores or pharmacies as a result of growing e-commerce trends enhance access to medical marijuana products.

A large number of manufacturers and suppliers are developing online websites to boost sales and provide timely delivery services, and convenience of shopping to consumers. The availability of a wide variety of products will drive customer engagement across online distribution channels.

West South Central U.S. medical marijuana market size was worth more than USD 1 billion in 2021. West South Central states in the U.S. have witnessed a surge in clinical research for the use of marijuana for medical reasons with government backing. In July 2022, the University of Louisiana Monroe School of Pharmacy secured approval from the Louisiana Senate to conduct cannabis testing and research.

Product Code: 2890

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definition
  • 1.2 Base estimates & working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 U.S. medical marijuana industry 360 degree synopsis, 2017 - 2030
    • 2.1.1 Business trends
    • 2.1.2 Application trends
    • 2.1.3 Route of administration trends
    • 2.1.4 Distribution channel trends
    • 2.1.5 Zonal trends

Chapter 3 US Medical Marijuana Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2030
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing application of marijuana for a myriad of medical conditions and symptoms
      • 3.3.1.2 Growing demand for medical marijuana legalization in several countries
      • 3.3.1.3 Rising number of R&D and clinical trial activities
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Few side effects might hinder the market growth
      • 3.3.2.2 Difficulty in medical marijuana business banking
  • 3.4 Growth potential analysis
    • 3.4.1 By application
    • 3.4.2 By route of administration
    • 3.4.3 By distribution channel
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape & guidelines
    • 3.6.1 Alaska
    • 3.6.2 Arizona
    • 3.6.3 Arkansas
    • 3.6.4 California
    • 3.6.5 Colorado
    • 3.6.6 Connecticut
    • 3.6.7 Delaware
    • 3.6.8 Florida
    • 3.6.9 Hawaii
    • 3.6.10 Illinois
    • 3.6.11 Louisiana
    • 3.6.12 Maine
    • 3.6.13 Maryland
    • 3.6.14 Massachusetts
    • 3.6.15 Michigan
    • 3.6.16 Minnesota
    • 3.6.17 Montana
    • 3.6.18 Missouri
    • 3.6.19 Nevada
    • 3.6.20 New Hampshire
    • 3.6.21 New Jersey
    • 3.6.22 New Mexico
    • 3.6.23 New York
    • 3.6.24 North Dakota
    • 3.6.25 Pennsylvania
    • 3.6.26 Ohio
    • 3.6.27 Oklahoma
    • 3.6.28 Oregon
    • 3.6.29 Rhode Island
    • 3.6.30 South Dakota
    • 3.6.31 Utah
    • 3.6.32 Virginia
    • 3.6.33 Vermont
    • 3.6.34 West Virginia
    • 3.6.35 Washington
    • 3.6.36 Washington D.C.
  • 3.7 Value chain analysis
  • 3.8 Legal requirement for distribution of medical marijuana
  • 3.9 Porter's analysis
  • 3.10 Competitive landscape, 2021
    • 3.10.1 Company matrix analysis, 2021
  • 3.11 PESTEL analysis

Chapter 4 US Medical Marijuana Market, By Application

  • 4.1 Key segment trends
  • 4.2 Pain Management
    • 4.2.1 Market size, by zones, 2017 - 2030 (USD Million)
    • 4.2.2 Neuropathic pain
      • 4.2.2.1 Market size, by zones, 2017 - 2030 (USD Million)
    • 4.2.3 Cancer pain
      • 4.2.3.1 Market size, by zones, 2017 - 2030 (USD Million)
    • 4.2.4 Others
      • 4.2.4.1 Market size, by zones, 2017 - 2030 (USD Million)
  • 4.3 Muscle spasms
    • 4.3.1 Market size, by zones, 2017 - 2030 (USD Million)
  • 4.4 Nausea
    • 4.4.1 Market size, by zones, 2017 - 2030 (USD Million)
  • 4.5 Anorexia
    • 4.5.1 Market size, by zones, 2017 - 2030 (USD Million)
  • 4.6 Seizures
    • 4.6.1 Market size, by zones, 2017 - 2030 (USD Million)
  • 4.7 Others
    • 4.7.1 Market size, by zones, 2017 - 2030 (USD Million)

Chapter 5 US Medical Marijuana Market, By Route of Administration

  • 5.1 Key segment trends
  • 5.2 Inhalation
    • 5.2.1 Market size, by zones, 2017 - 2030 (USD Million)
  • 5.3 Oral
    • 5.3.1 Market size, by zones, 2017 - 2030 (USD Million)
  • 5.4 Topical
    • 5.4.1 Market size, by zones, 2017 - 2030 (USD Million)

Chapter 6 US Medical Marijuana Market, By Distribution Channel

  • 6.1 Key segment trends
  • 6.2 Dispensaries
    • 6.2.1 Market size, by zones, 2017 - 2030 (USD Million)
  • 6.3 Online
    • 6.3.1 Market size, by zones, 2017 - 2030 (USD Million)

Chapter 7 US Medical Marijuana Market, By Zone

  • 7.1 Key zonal trends
  • 7.2 North East
    • 7.2.1 Market size, by states, 2017 - 2030 (USD Million)
    • 7.2.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.2.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
    • 7.2.3 Market size, by route of administration, 2017 - 2030 (USD Million)
    • 7.2.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.2.5 Connecticut
      • 7.2.5.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.2.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.2.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.2.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.2.6 Maine
      • 7.2.6.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.2.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.2.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.2.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.2.7 Massachusetts
      • 7.2.7.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.2.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.2.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.2.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.2.8 New Hampshire
      • 7.2.8.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.2.8.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.2.8.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.2.8.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.2.9 Rhode Island
      • 7.2.9.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.2.9.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.2.9.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.2.9.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.2.10 Vermont
      • 7.2.10.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.2.10.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.2.10.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.2.10.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.2.11 New Jersey
      • 7.2.11.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.2.11.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.2.11.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.2.11.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.2.12 New York
      • 7.2.12.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.2.12.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.2.12.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.2.12.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.2.13 Pennsylvania
      • 7.2.13.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.2.13.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.2.13.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.2.13.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 7.3 East North Central
    • 7.3.1 Market size, by states, 2017 - 2030 (USD Million)
    • 7.3.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
    • 7.3.3 Market size, by route of administration, 2017 - 2030 (USD Million)
    • 7.3.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.3.5 Illinois
      • 7.3.5.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.3.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.3.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.3.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.3.6 Michigan
      • 7.3.6.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.3.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.3.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.3.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.3.7 Ohio
      • 7.3.7.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.3.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.3.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.3.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 7.4 South Atlantic
    • 7.4.1 Market size, by states, 2017 - 2030 (USD Million)
    • 7.4.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
    • 7.4.3 Market size, by route of administration, 2017 - 2030 (USD Million)
    • 7.4.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.4.5 Delaware
      • 7.4.5.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.4.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.4.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.4.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.4.6 Florida
      • 7.4.6.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.4.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.4.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.4.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.4.7 Maryland
      • 7.4.7.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.4.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.4.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.4.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.4.8 Washington D.C.
      • 7.4.8.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.4.8.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.4.8.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.4.8.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.4.9 Virginia
      • 7.4.9.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.4.9.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.4.9.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.4.9.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.4.10 West Virginia
      • 7.4.10.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.4.10.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.4.10.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.4.10.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 7.5 West North Central
    • 7.5.1 Market size, by states, 2017 - 2030 (USD Million)
    • 7.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
    • 7.5.3 Market size, by route of administration, 2017 - 2030 (USD Million)
    • 7.5.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.5.5 Minnesota
      • 7.5.5.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.5.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.5.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.5.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.5.6 Missouri
      • 7.5.6.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.5.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.5.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.5.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.5.7 North Dakota
      • 7.5.7.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.5.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.5.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.5.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.5.8 South Dakota
      • 7.5.8.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.5.8.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.5.8.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.5.8.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 7.6 Pacific Central
    • 7.6.1 Market size, by states, 2017 - 2030 (USD Million)
    • 7.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
    • 7.6.3 Market size, by route of administration, 2017 - 2030 (USD Million)
    • 7.6.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.6.5 California
      • 7.6.5.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.6.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.6.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.6.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.6.6 Alaska
      • 7.6.6.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.6.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.6.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.6.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.6.7 Hawaii
      • 7.6.7.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.6.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.6.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.6.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.6.8 Oregon
      • 7.6.8.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.6.8.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.6.8.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.6.8.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.6.9 Washington
      • 7.6.9.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.6.9.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.6.9.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.6.9.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 7.7 Mountain States
    • 7.7.1 Market size, by states, 2017 - 2030 (USD Million)
    • 7.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.7.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
    • 7.7.3 Market size, by route of administration, 2017 - 2030 (USD Million)
    • 7.7.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.7.5 Arizona
      • 7.7.5.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.7.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.7.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.7.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.7.6 Colorado
      • 7.7.6.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.7.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.7.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.7.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.7.7 Nevada
      • 7.7.7.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.7.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.7.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.7.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.7.8 New Mexico
      • 7.7.8.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.7.8.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.7.8.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.7.8.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.7.9 Montana
      • 7.7.9.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.7.9.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.7.9.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.7.9.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.7.10 Utah
      • 7.7.10.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.7.10.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.7.10.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.7.10.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
  • 7.8 West South Central
    • 7.8.1 Market size, by states, 2017 - 2030 (USD Million)
    • 7.8.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.8.2.1 Market size, by pain management, 2017 - 2030 (USD Million)
    • 7.8.3 Market size, by route of administration, 2017 - 2030 (USD Million)
    • 7.8.4 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.8.5 Arkansas
      • 7.8.5.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.8.5.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.8.5.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.8.5.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.8.6 Oklahoma
      • 7.8.6.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.8.6.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.8.6.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.8.6.3 Market size, by distribution channel, 2017 - 2030 (USD Million)
    • 7.8.7 Louisiana
      • 7.8.7.1 Market size, by application, 2017 - 2030 (USD Million)
        • 7.8.7.1.1 Market size, by pain management, 2017 - 2030 (USD Million)
      • 7.8.7.2 Market size, by route of administration, 2017 - 2030 (USD Million)
      • 7.8.7.3 Market size, by distribution channel, 2017 - 2030 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard
  • 8.2 Canopy Growth Corporation
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Service landscape
    • 8.2.4 SWOT analysis
  • 8.3 Aurora Cannabis, Inc.
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Service landscape
    • 8.3.4 SWOT analysis
  • 8.4 GW Pharmaceuticals
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Service landscape
    • 8.4.4 SWOT analysis
  • 8.5 Medical Marijuana, Inc.
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Service landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 Cannabis Sativa, Inc.
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Service landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 Emerald Health Therapeutics Inc.
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Service landscape
    • 8.7.4 SWOT analysis
  • 8.8 The Cronos Group Inc.
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Service landscape
    • 8.8.4 SWOT analysis
  • 8.9 Tilray
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Service landscape
    • 8.9.4 SWOT analysis
  • 8.10 Lexaria Bioscience Corp
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Service landscape
    • 8.10.4 SWOT analysis
  • 8.11 Curaleaf
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Service landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
  • 8.12 Green Roads
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Service landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 SWOT analysis
  • 8.13 CHARLOTTE'S WEB
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Service landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 SWOT analysis
  • 8.14 Gaia Herbs
    • 8.14.1 Business overview
    • 8.14.2 Financial data
    • 8.14.3 Service landscape
    • 8.14.4 Strategic outlook
    • 8.14.5 SWOT analysis
  • 8.15 Folium Biosciences
    • 8.15.1 Business overview
    • 8.15.2 Financial data
    • 8.15.3 Service landscape
    • 8.15.4 Strategic outlook
    • 8.15.5 SWOT analysis
Product Code: 2890

Data Tables

  • TABLE 1. U.S. medical marijuana market, 2017 - 2021 (USD Million)
  • TABLE 2. U.S. medical marijuana market, 2022 - 2030 (USD Million)
  • TABLE 3. U.S. medical marijuana market, by application, 2017 - 2021 (USD Million)
  • TABLE 4. U.S. medical marijuana market, by application, 2022 - 2030 (USD Million)
  • TABLE 5. U.S. medical marijuana market, by route of administration, 2017 - 2021 (USD Million)
  • TABLE 6. U.S. medical marijuana market, by route of administration, 2022 - 2030 (USD Million)
  • TABLE 7. U.S. medical marijuana market, by distribution channel, 2017 - 2021 (USD Million)
  • TABLE 8. U.S. medical marijuana market, by distribution channel, 2022 - 2030 (USD Million)
  • TABLE 9. U.S. medical marijuana market, by zones, 2017 - 2021 (USD Million)
  • TABLE 10. U.S. medical marijuana market, by zones, 2022 - 2030 (USD Million)
  • TABLE 11. Industry impact forces
  • TABLE 12. U.S. pain management market size, by zone, 2017 - 2021, (USD Million)
  • TABLE 13. U.S. pain management market size, by zones, 2022 - 2030, (USD Million)
  • TABLE 14. U.S. neuropathic pain market size, by zone, 2017 - 2021, (USD Million)
  • TABLE 15. U.S. neuropathic pain market size, by zones, 2022 - 2030, (USD Million)
  • TABLE 16. U.S. cancer pain market size, by zone, 2017 - 2021, (USD Million)
  • TABLE 17. U.S. cancer pain market size, by zones, 2022 - 2030, (USD Million)
  • TABLE 18. U.S. others market size, by zone, 2017 - 2021, (USD Million)
  • TABLE 19. U.S. others market size, by zones, 2022 - 2030, (USD Million)
  • TABLE 20. U.S. muscle spasm market size, by zone, 2017 - 2021, (USD Million)
  • TABLE 21. U.S. muscle spasm market size, by zones, 2022 - 2030, (USD Million)
  • TABLE 22. U.S. nausea market size, by zone, 2017 - 2021, (USD Million)
  • TABLE 23. U.S. nausea market size, by zones, 2022 - 2030, (USD Million)
  • TABLE 24. U.S. anorexia market size, by zone, 2017 - 2021, (USD Million)
  • TABLE 25. U.S. anorexia market size, by zones, 2022 - 2030, (USD Million)
  • TABLE 26. U.S. seizures market size, by zone, 2017 - 2021, (USD Million)
  • TABLE 27. U.S. seizures market size, by zones, 2022 - 2030, (USD Million)
  • TABLE 28. U.S. others market size, by zone, 2017 - 2021, (USD Million)
  • TABLE 29. U.S. others market size, by zones, 2022 - 2030, (USD Million)
  • TABLE 30. U.S. inhalation market size, by zone, 2017 - 2021, (USD Million)
  • TABLE 31. U.S. inhalation market size, by zones, 2022 - 2030, (USD Million)
  • TABLE 32. U.S. oral market size, by zone, 2017 - 2021, (USD Million)
  • TABLE 33. U.S. oral market size, by zones, 2022 - 2030, (USD Million)
  • TABLE 34. U.S. topical market size, by zone, 2017 - 2021, (USD Million)
  • TABLE 35. U.S. topical market size, by zones, 2022 - 2030, (USD Million)
  • TABLE 36. U.S. dispensaries market size, by zone, 2017 - 2021, (USD Million)
  • TABLE 37. U.S. dispensaries market size, by zones, 2022 - 2030, (USD Million)
  • TABLE 38. U.S. online market size, by zone, 2017 - 2021, (USD Million)
  • TABLE 39. U.S. online market size, by zones, 2022 - 2030, (USD Million)
  • TABLE 40. North East medical marijuana market, by states, 2017-2021, (USD Million)
  • TABLE 41. North East medical marijuana market, by states, 2022-2030, (USD Million)
  • TABLE 42. North East medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 43. North East medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 44. North East medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 45. North East medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 46. North East medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 47. North East medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 48. North East medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 49. North East medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 50. Connecticut medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 51. Connecticut medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 52. Connecticut medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 53. Connecticut medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 54. Connecticut medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 55. Connecticut medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 56. Connecticut medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 57. Connecticut medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 58. Maine medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 59. Maine medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 60. Maine medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 61. Maine medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 62. Maine medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 63. Maine medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 64. Maine medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 65. Maine medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 66. Massachusetts medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 67. Massachusetts medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 68. Massachusetts medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 69. Massachusetts medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 70. Massachusetts medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 71. Massachusetts medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 72. Massachusetts medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 73. Massachusetts medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 74. New Hampshire medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 75. New Hampshire medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 76. New Hampshire medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 77. New Hampshire medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 78. New Hampshire medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 79. New Hampshire medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 80. New Hampshire medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 81. New Hampshire medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 82. Rhode Island medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 83. Rhode Island medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 84. Rhode Island medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 85. Rhode Island medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 86. Rhode Island medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 87. Rhode Island medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 88. Rhode Island medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 89. Rhode Island medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 90. Vermont medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 91. Vermont medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 92. Vermont medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 93. Vermont medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 94. Vermont medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 95. Vermont medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 96. Vermont medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 97. Vermont medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 98. New Jersey medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 99. New Jersey medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 100. New Jersey medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 101. New Jersey medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 102. New Jersey medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 103. New Jersey medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 104. New Jersey medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 105. New Jersey medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 106. New York medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 107. New York medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 108. New York medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 109. New York medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 110. New York medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 111. New York medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 112. New York medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 113. New York medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 114. Pennsylvania medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 115. Pennsylvania medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 116. Pennsylvania medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 117. Pennsylvania medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 118. Pennsylvania medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 119. Pennsylvania medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 120. Pennsylvania medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 121. Pennsylvania medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 122. East North Central medical marijuana market, by states, 2017-2021, (USD Million)
  • TABLE 123. East North Central medical marijuana market, by states, 2022-2030, (USD Million)
  • TABLE 124. East North Central medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 125. East North Central medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 126. East North Central medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 127. East North Central medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 128. East North Central medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 129. East North Central medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 130. East North Central medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 131. East North Central medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 132. Illinois medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 133. Illinois medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 134. Illinois medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 135. Illinois medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 136. Illinois medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 137. Illinois medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 138. Illinois medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 139. Illinois medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 140. Michigan medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 141. Michigan medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 142. Michigan medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 143. Michigan medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 144. Michigan medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 145. Michigan medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 146. Michigan medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 147. Michigan medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 148. Ohio medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 149. Ohio medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 150. Ohio medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 151. Ohio medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 152. Ohio medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 153. Ohio medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 154. Ohio medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 155. Ohio medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 156. West South Central medical marijuana market, by states, 2017-2021, (USD Million)
  • TABLE 157. West South Central medical marijuana market, by states, 2022-2030, (USD Million)
  • TABLE 158. West South Central medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 159. West South Central medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 160. West South Central medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 161. West South Central medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 162. West South Central medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 163. West South Central medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 164. West South Central medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 165. West South Central medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 166. Arkansas medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 167. Arkansas medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 168. Arkansas medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 169. Arkansas medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 170. Arkansas medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 171. Arkansas medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 172. Arkansas medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 173. Arkansas medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 174. Oklahoma medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 175. Oklahoma medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 176. Oklahoma medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 177. Oklahoma medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 178. Oklahoma medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 179. Oklahoma medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 180. Oklahoma medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 181. Oklahoma medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 182. Louisiana medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 183. Louisiana medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 184. Louisiana medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 185. Louisiana medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 186. Louisiana medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 187. Louisiana medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 188. Louisiana medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 189. Louisiana medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 190. South Atlantic medical marijuana market, by states, 2017-2021, (USD Million)
  • TABLE 191. South Atlantic medical marijuana market, by states, 2022-2030, (USD Million)
  • TABLE 192. South Atlantic medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 193. South Atlantic medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 194. South Atlantic medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 195. South Atlantic medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 196. South Atlantic medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 197. South Atlantic medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 198. South Atlantic medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 199. South Atlantic medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 200. Delaware medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 201. Delaware medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 202. Delaware medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 203. Delaware medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 204. Delaware medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 205. Delaware medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 206. Delaware medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 207. Delaware medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 208. Florida medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 209. Florida medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 210. Florida medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 211. Florida medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 212. Florida medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 213. Florida medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 214. Florida medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 215. Florida medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 216. Maryland medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 217. Maryland medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 218. Maryland medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 219. Maryland medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 220. Maryland medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 221. Maryland medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 222. Maryland medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 223. Maryland medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 224. Washington DC medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 225. Washington DC medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 226. Washington DC medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 227. Washington DC medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 228. Washington DC medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 229. Washington DC medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 230. Washington DC medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 231. Washington DC medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 232. Virginia medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 233. Virginia medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 234. Virginia medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 235. Virginia medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 236. Virginia medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 237. Virginia medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 238. Virginia medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 239. Virginia medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 240. West Virginia medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 241. West Virginia medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 242. West Virginia medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 243. West Virginia medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 244. West Virginia medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 245. West Virginia medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 246. West Virginia medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 247. West Virginia medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 248. West North Central medical marijuana market, by states, 2017-2021, (USD Million)
  • TABLE 249. West North Central medical marijuana market, by states, 2022-2030, (USD Million)
  • TABLE 250. West North Central medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 251. West North Central medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 252. West North Central medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 253. West North Central medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 254. West North Central medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 255. West North Central medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 256. West North Central medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 257. West North Central medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 258. Minnesota medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 259. Minnesota medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 260. Minnesota medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 261. Minnesota medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 262. Minnesota medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 263. Minnesota medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 264. Minnesota medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 265. Minnesota medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 266. Missouri medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 267. Missouri medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 268. Missouri medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 269. Missouri medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 270. Missouri medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 271. Missouri medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 272. Missouri medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 273. Missouri medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 274. North Dakota medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 275. North Dakota medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 276. North Dakota medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 277. North Dakota medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 278. North Dakota medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 279. North Dakota medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 280. North Dakota medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 281. North Dakota medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 282. South Dakota medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 283. South Dakota medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 284. South Dakota medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 285. South Dakota medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 286. South Dakota medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 287. South Dakota medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 288. South Dakota medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 289. South Dakota medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 290. Pacific Central medical marijuana market, by states, 2017-2021, (USD Million)
  • TABLE 291. Pacific Central medical marijuana market, by states, 2022-2030, (USD Million)
  • TABLE 292. Pacific Central medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 293. Pacific Central medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 294. Pacific Central medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 295. Pacific Central medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 296. Pacific Central medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 297. Pacific Central medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 298. Pacific Central medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 299. Pacific Central medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 300. Alaska medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 301. Alaska medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 302. Alaska medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 303. Alaska medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 304. Alaska medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 305. Alaska medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 306. Alaska medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 307. Alaska medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 308. California medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 309. California medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 310. California medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 311. California medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 312. California medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 313. California medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 314. California medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 315. California medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 316. Hawaii medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 317. Hawaii medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 318. Hawaii medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 319. Hawaii medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 320. Hawaii medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 321. Hawaii medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 322. Hawaii medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 323. Hawaii medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 324. Oregon medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 325. Oregon medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 326. Oregon medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 327. Oregon medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 328. Oregon medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 329. Oregon medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 330. Oregon medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 331. Oregon medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 332. Washington medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 333. Washington medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 334. Washington medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 335. Washington medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 336. Washington medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 337. Washington medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 338. Washington medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 339. Washington medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 340. Mountain States medical marijuana market, by states, 2017-2021, (USD Million)
  • TABLE 341. Mountain States medical marijuana market, by states, 2022-2030, (USD Million)
  • TABLE 342. Mountain States medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 343. Mountain States medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 344. Mountain States medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 345. Mountain States medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 346. Mountain States medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 347. Mountain States medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 348. Mountain States medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 349. Mountain States medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 350. Arizona medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 351. Arizona medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 352. Arizona medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 353. Arizona medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 354. Arizona medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 355. Arizona medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 356. Arizona medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 357. Arizona medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 358. Colorado medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 359. Colorado medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 360. Colorado medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 361. Colorado medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 362. Colorado medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 363. Colorado medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 364. Colorado medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 365. Colorado medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 366. Nevada medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 367. Nevada medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 368. Nevada medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 369. Nevada medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 370. Nevada medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 371. Nevada medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 372. Nevada medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 373. Nevada medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 374. New Mexico medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 375. New Mexico medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 376. New Mexico medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 377. New Mexico medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 378. New Mexico medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 379. New Mexico medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 380. New Mexico medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 381. New Mexico medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 382. Montana medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 383. Montana medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 384. Montana medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 385. Montana medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 386. Montana medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 387. Montana medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 388. Montana medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 389. Montana medical marijuana market, by distribution channel, 2022-2030, (USD Million)
  • TABLE 390. Utah medical marijuana market, by application, 2017-2021, (USD Million)
  • TABLE 391. Utah medical marijuana market, by application, 2022-2030, (USD Million)
  • TABLE 392. Utah medical marijuana market, by pain management, 2017-2021, (USD Million)
  • TABLE 393. Utah medical marijuana market, by pain management, 2022-2030, (USD Million)
  • TABLE 394. Utah medical marijuana market, by route of administration, 2017-2021, (USD Million)
  • TABLE 395. Utah medical marijuana market, by route of administration, 2022-2030, (USD Million)
  • TABLE 396. Utah medical marijuana market, by distribution channel, 2017-2021, (USD Million)
  • TABLE 397. Utah medical marijuana market, by distribution channel, 2022-2030, (USD Million)

Charts & Figures

  • FIG 1. Top-down approach
  • FIG 2. Breakdown of primary participants
  • FIG 3. U.S. medical marijuana industry 360 degree synopsis, 2017 - 2030
  • FIG 4. Industry segmentation
  • FIG 5. Industry landscape, 2017-2030 (USD Million)
  • FIG 6. Growth potential analysis, by application
  • FIG 7. Growth potential analysis, by route of administration
  • FIG 8. Growth potential analysis, by distribution channel
  • FIG 9. Porter's analysis
  • FIG 10. Company matrix analysis, 2021
  • FIG 11. PESTEL analysis
  • FIG 12. Key segment trends, by application
  • FIG 13. Key segment trends, by route of administration
  • FIG 14. Key segment trends, by distribution channel
  • FIG 15. Key zonal trends
  • FIG 16. Strategy dashboard, 2021
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!